2013
DOI: 10.1074/jbc.m112.445932
|View full text |Cite
|
Sign up to set email alerts
|

The Rare TXNRD1_v3 (“v3”) Splice Variant of Human Thioredoxin Reductase 1 Protein Is Targeted to Membrane Rafts by N-Acylation and Induces Filopodia Independently of Its Redox Active Site Integrity

Abstract: Background: The TXNRD1_v3 ("v3") protein is a rare variant of human thioredoxin reductase 1. Results: Membrane targeting of v3 occurs by N-terminal myristoylation and palmitoylation, and its overexpression triggers induction of filopodia independently of its redox active site integrity. Conclusion:The v3 protein is targeted to membrane rafts. Significance: These results imply that v3, shown to be targeted to membrane rafts, may be involved in signaling events.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 21 publications
(11 citation statements)
references
References 68 publications
0
10
0
Order By: Relevance
“…One of TrxR1 variants has been reported to be modified by fatty acid at its N-terminal MGC motif [18] . Protein S-acylation is a common post-translational modification of proteins [19] .…”
Section: Resultsmentioning
confidence: 99%
“…One of TrxR1 variants has been reported to be modified by fatty acid at its N-terminal MGC motif [18] . Protein S-acylation is a common post-translational modification of proteins [19] .…”
Section: Resultsmentioning
confidence: 99%
“…However, in general, myristoylation is insufficient for raft targeting. Instead, a number of proteins are simultaneously myristoylated and palmitoylated, with this dual acylation efficiently promoting DRM affinity for proteins including G subunits, Src-family tyrosine kinases, reggie-1/flotillin-2, BAALC 1-6-8, UL-11 and TXNRD1-v3 (Moffett, Brown et al 2000, Mukherjee, Arnaud et al 2003, Neumann-Giesen, Falkenbach et al 2004, Wang, Tian et al 2005, Koshizuka, Kawaguchi et al 2007, Cebula, Moolla et al 2013. In surprisingand as yet unexplained -contrast with these results, myristoylated/palmitoylated constructs often do not partition efficiently into the Lo phase of GPMVs (Baumgart, Hammond et al 2007, Sengupta, Hammond et al 2008, Johnson, Stinson et al 2010.…”
Section: Y R I S T O Y L a T I O Nmentioning
confidence: 99%
“…One TrxR1 variant was reported to be palmitoylated at an Nterminal Cys residue [34] that is located outside the active site. The TrxR1 used in this study does not include the N-terminal extension.…”
Section: Active Site Cys/sec Residue(s) Of Trxr1 As Target(s) For Palmentioning
confidence: 99%